Group II: Diabetic control Group III: Diabetic rats treated with MCSEt1 (150 mg/kg b.w./day) in
aqueous solution orally for 30 days.
Group IV: Diabetic rats treated with MCSEt2 (150 mg/kg b.w./day) in
aqueous solution orally for 30 days.
Group V: Diabetic rats administered with glibenclamide (600 mg/kg b.w./rat/day) in aqueous medium orally for 30 days (Pari and Umamaheswari 2000)